18F-Labeled o‑aminopyridyl alkynyl radioligands targeting colony-stimulating factor 1 receptor for neuroinflammation imaging

Abstract

We report the design, synthesis and evaluation of five o‑aminopyridyl alkynyl derivatives as colony-stimulating factor 1 receptor (CSF-1R) ligands. Compounds 4 and 5 with the fluoroethoxy group at the meta- or para-position of the phenyl ring possessed nanomolar inhibitory potency against CSF-1R with IC50 values of 7.6nM and 2.3nM, respectively. Radioligands [18F]4 and [18F]5 were obtained in radiochemical yields of 17.2±5.3% (n=5, decay-corrected) and 14.0±4.3% (n=4, decay-corrected), with radiochemical purity of>99% and molar activity of 9-12GBq/μmol (n=5) and 6-8GBq/μmol (n=4), respectively. In biodistribution studies, radioligands [18F]4 and [18F]5 showed moderate brain uptake in male ICR mice with 1.52±0.15 and 0.91±0.07% ID/g, respectively, at 15min. Metabolic stability studies in mouse brain revealed that [18F]4 exhibited high stability while [18F]5 suffered from low stability. Higher accumulation of [18F]4 in the brain of lipopolysaccharide (LPS)-treated mice was observed, and further pretreatment of BLZ945 or CPPC led to remarkable reduction, indicating specific binding of [18F]4 to CSF-1R.